Status:
UNKNOWN
National Gilles De La Tourette Study Group
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Tourette Syndrome
Eligibility:
All Genders
15-80 years
Brief Summary
Tourette syndrome is rare. In France, about 3000 patients have a severe form of the disease. The aim of this study is to collect clinical characteristics in 200 patients with Tourette syndrome.
Eligibility Criteria
Inclusion
- Tourette syndrome
Exclusion
- severe cognitive disorders
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00169351
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique-HÔPITAL PITIÉ-SALPETRIERE
Paris, France